Eli Lilly and Company will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 28, 2026. Daniel M. Skovronsky, M.D., Ph.D., chief scientific and product officer, and president ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results